Such genomic technologies not only help to identify cancers, but also offer opportunities for assessing the potential efficacy of different treatment options. By analyzing the genomic profile of a ...

“The broad capabilities of the OncoExTra assay detected therapeutically actionable and other clinically relevant genomic events that can inform clinical decision-making for patients with advanced ...

Illumina is teaming up with Tempus AI for a project aimed at promoting the use of DNA sequencing tests across all major areas of disease. The companies said they will work together to train artificial ...

Led by a team from Buffalo, N.Y.-based Roswell Park Comprehensive Cancer Center, researchers have created the largest and most detailed profile of genetic mutations found in African American women ...

Accurate genomic profiling is essential for clinical decision-making and optimizing treatment recommendations. Tumor-only sequencing has been adopted by many laboratories to guide precision oncology ...

New ctDNA-based test offers a flexible, guideline-driven solution for patients with advanced solid tumors when tissue is limited or unavailable “The launch of our liquid biopsy test positions us at ...

PALO ALTO, Calif.--(BUSINESS WIRE)--Researchers at FidoCure and Stanford University have published a peer-reviewed article in Nature Scientific Reports titled, "Real-world evidence couples genomic ...

New ctDNA-based test offers a flexible, guideline-driven solution for patients with advanced solid tumors when tissue is limited or unavailable NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of ...